Protara Therapeutics, Inc. (TARA)
↓ Download CSV- Sector Manufacturing
- Fiscal year ends Dec 31
Key ratios (FY2025)
-29.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$64.55M | -$49.15M | -$43.61M | -$67.06M | -$47.49M | -$34.44M | -$7.83M | -$21.37M | -$30.36M | -$28.70M |
| Net Income | -$57.44M | -$44.60M | -$40.42M | -$65.95M | -$47.25M | -$33.98M | -$7.83M | -$20.73M | -$29.96M | -$28.53M |
| EPS (Diluted) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | — | — | — | — | — |
| Total Assets | $209.47M | $181.45M | $78.95M | $113.29M | $172.60M | $203.16M | $1.22M | $23.52M | $43.98M | $43.52M |
| Total Liabilities | $13.06M | $14.32M | $10.63M | $11.21M | $10.68M | $3.91M | $3.35M | $3.08M | $9.24M | $5.08M |
| Shareholders' Equity | $196.41M | $167.13M | $68.32M | $102.08M | $161.91M | $199.24M | -$2.13M | $4.78M | $34.74M | $38.44M |
| Cash & Equivalents | $49.66M | $162.80M | $39.59M | $24.13M | $35.72M | $168.60M | $564.0K | $19.37M | $21.17M | $36.39M |
| Operating Cash Flow | -$56.37M | -$35.81M | -$37.56M | -$26.46M | -$34.50M | -$23.41M | -$5.01M | -$23.23M | -$22.35M | -$23.69M |
| Capital Expenditures | $94.0K | $63.0K | $45.0K | $120.0K | $596.0K | $884.0K | $475.0K | $119.0K | $35.0K | $271.0K |
| Shares Outstanding | 53.59M | 35.04M | 11.36M | 11.27M | 11.24M | 11.21M | 2.63M | 481.1K | 17.67M | 16.60M |